Anderson; Kevin P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Anderson; Kevin P..The latest application filed is for "antiviral oligonucleotides having a conserved g4 core sequence".

Company Profile

0.13.8

Anderson; Kevin P. - Carlsbad CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antiviral Oligonucleotides Having a Conserved G4 Core Sequence App 20110124715 - Hanecak; Ronnie C. ; et al.	2011-05-26
Antiviral oligonucleotides having a conserved G4 core sequence App 20070015723 - Hanecak; Ronnie C. ; et al.	2007-01-18
Modulation of telomere length by oligonucleotides having a G-core sequence Grant 7,067,497 - Hanecak , et al. June 27, 2	2006-06-27
Compositions and methods for treatment of hepatitis C virus-associated diseases Grant 6,995,146 - Anderson , et al. February 7, 2	2006-02-07
Antisense modulation of interleukin 12 P35 subunit expression App 20050261228 - Bennett, C. Frank ; et al.	2005-11-24
Compositions and mehtods for treatment of Hepatitis C virus-associated diseases App 20040049021 - Anderson, Kevin P. ; et al.	2004-03-11
Compositions and methods for treatment of Hepatitis C virus-associated diseases App 20040033978 - Anderson, Kevin P. ; et al.	2004-02-19
Compositions and methods for treatment of hepatitis C virus-associated diseases App 20030171313 - Anderson, Kevin P. ; et al.	2003-09-11
Compositions and methods for treatment of hepatitis C virus-associated diseases Grant 6,608,191 - Anderson , et al. August 19, 2	2003-08-19
Modulation of telomere length by oligonucleotides having a G-core sequence App 20030096776 - Hanecak, Ronnie C. ; et al.	2003-05-22
Compositions and methods for treatment of Hepatitis C virus-associated diseases Grant 6,423,489 - Anderson , et al. July 23, 2	2002-07-23
Compositions and methods for treatment of Hepatitis C virus-associated diseases Grant 6,391,542 - Anderson , et al. May 21, 2	2002-05-21
Compositions and methods for antisense inhibition of protein translation App 20020052331 - Baker, Brenda ; et al.	2002-05-02
Compositions and methods for treatment of hepatitis C virus-associated diseases Grant 6,284,458 - Anderson , et al. September 4, 2	2001-09-04
Compositions and methods for treatment of hepatitis C virus-associated diseases Grant 6,174,868 - Anderson , et al. January 16, 2	2001-01-16
Composition and method for treatment of CMV infections Grant 6,153,595 - Draper , et al. November 28, 2	2000-11-28
Antisense inhibition of hepatitis B virus replication Grant 5,985,662 - Anderson , et al. November 16, 1	1999-11-16
Oligonucleotides having a conserved G4 core sequence Grant 5,952,490 - Hanecak , et al. September 14, 1	1999-09-14
Antisense inhibition of ICAM-1, E-selectin, and CMV IE1/IE2 Grant 5,789,573 - Baker , et al. August 4, 1	1998-08-04
Oligonucleotides for modulating the effects of cytomegalovirus infections Grant 5,591,720 - Anderson , et al. January 7, 1	1997-01-07
Oligonucleotide therapies for modulating the effects of herpes viruses Grant 5,514,577 - Draper , et al. May 7, 1	1996-05-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.